SCHEMBL17035183

SCHEMBL17035183

c1ccc(-c2cc(-c3nc(-c4ccc5ccccc5c4)nc(-c4ccc5ccccc5c4)n3)cc(-c3cccc4c3ccc3c(-c5ccccc5)nc5ccccc5c34)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
ATM Q13315 1/20 0.40
AURKA O14965 1/20 0.36
AURKB Q96GD4 1/20 0.36
ADORA2A P29274 4/20 0.36
ADORA1 P30542 3/20 0.36
CYP1A2 P05177 4/20 0.34
CYP3A4 P08684 3/20 0.34
CYP2C9 P11712 3/20 0.34
CYP2B6 P20813 2/20 0.34
AHR P35869 2/20 0.34
NR1I3 Q14994 2/20 0.34
VDR P11473 1/20 0.34
DHODH Q02127 2/20 0.34
MET P08581 1/20 0.34
KDM4E B2RXH2 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
ALDH1A1 P00352 2/20 0.33
HSD17B10 Q99714 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17035100 0.95 MEN1 (0.43) MEN1KMT2AATMAURKAAURKB
SCHEMBL17035099 0.94 MEN1 (0.43) MEN1KMT2AATMAURKAAURKB
SCHEMBL17035097 0.92 MEN1 (0.46) MEN1KMT2AATMAURKAAURKB
SCHEMBL17035101 0.91 NPC1 (0.38) MEN1KMT2AATMAURKAAURKB
SCHEMBL17035102 0.91 CYP11B1 (0.46) MEN1KMT2ACYP1A2CYP3A4CYP2C9
SCHEMBL17035007 0.91 MEN1 (0.42) MEN1KMT2AATMAURKAAURKB
SCHEMBL17035093 0.91 MEN1 (0.46) MEN1KMT2AATMADORA2ACYP1A2
SCHEMBL17035070 0.90 ALDH1A1 (0.36) MEN1KMT2AATMAURKAAURKB
SCHEMBL17035013 0.90 MEN1 (0.40) MEN1KMT2AATMAURKAAURKB
SCHEMBL17034929 0.90 PIM1 (0.37) MEN1KMT2AATMAURKAAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 MEN1 476/4885KMT2A 2092/4885ATM 1334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.